Femasys Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| FEMY | UTMD | AMS.L | TFX | MMSI | CBHD.F | |
|---|---|---|---|---|---|---|
| Market cap | 12.06M | 206.20M | 616.70M | 6.35B | 5.43B | 15.59B |
| P/E (TTM) | — | 21.7 | 141.6 | — | 33.9 | 37.8 |
| Forward P/E | -0.7 | — | 16.7 | 13.7 | 19.4 | 17.6 |
| Price/book | 1.1 | 1.9 | 2.4 | 2.2 | 3.1 | 8.2 |
| Dividend yield | — | 1.73% | — | 0.91% | — | 4.66% |
| 1-year change | −90.78% | +20.72% | +32.55% | +38.12% | +4.76% | −20.28% |
| Today | +2.86% | +3.43% | +0.05% | +7.09% | +7.69% | +0.29% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All FEMY news ›Femasys (NASDAQ:FEMY) Upgraded at Wall Street Zen
Posted by Sarita Garza on Oct 20th, 2026 Wall Street Zen upgraded shares of Femasys (NASDAQ:FEMY – Free Report) from a strong sell rating to a sell rating in a report released on Saturday morning,Wall Street Zen reports. View Our Latest…
AEye: Orin Hirschman reports 8.3% passive stake
Investment firms and a family hold 3.86M AEye (LIDR) shares in a reported passive stake. Stock Titan - [SCHEDULE 13G] AEye, Inc. Passive Investment Disclosure (>5%) AEye: Orin Hirschman reports 8.3% passive stake The ownership disclosure…
Femasys: Launch Is Funded. If The Sales Force Delivers, Then The Company Is In Tall Cotton.
Femasys is a commercial-stage medtech company targeting OB/GYNs with in-office fertility and permanent birth control solutions. See why FEMY stock is a Buy. Rasi Bhadramani/iStock via Getty Images Femasys (FEMY) (the "Company") is a…
Femasys: Empery reports 5.6% passive stake
A fund manager reports a passive 468,750-share stake in Femasys (FEMY). Stock Titan - [SCHEDULE 13G] FEMASYS INC Passive Investment Disclosure (>5%) Femasys: Empery reports 5.6% passive stake The 5.60% ownership figure is calculated…
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
Yiren Digital Provides Further Update on Operations The trial targets one-year pregnancy-rate data for an FDA submission, while European approval enables post-market data collection. Femasys (FEMY) has doubled actively enrolling sites in…
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
Nokia Corporation Interim Report for Q3 2026 Supermicro Introduces the NVIDIA Vera CPU Rack, a 256 CPU, 100% Liquid-Cooled Rack-Scale Solution, Complementing the NVIDIA Vera Rubin Platform, for Agentic AI at Scale argenx Reports Third…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net3
- seekingalpha.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.